Candida krusei--a serious complication in patients with hematological malignancies: successful treatment with caspofungin.
Candida krusei infections are serious complications in neutropenic patients with hematological malignancies. We report the successful treatment of C. krusei infection with caspofungin in 3 allogeneic hematopoietic stem cell transplant recipients and 1 patient with induction chemotherapy for acute myeloid leukemia.
Conen
A
A
Division of Infectious Diseases & Hospital Epidemiology, University Hospital Basel, Basel, Switzerland.
Weisser
M
M
Jörg
C Orasch
CO
Battegay
M
M
Trampuz
A
A
Frei
R
R
Christen
S
S
Heim
D
D
Gratwohl
A
A
Flückiger
U
U
D000328:Adult; D000935:Antifungal Agents / Q000627:therapeutic use*; D002175:Candida / Q000145:classification / Q000187:drug effects*; D002177:Candidiasis / Q000188:drug therapy* / Q000382:microbiology; D000077336:Caspofungin; D054714:Echinocandins / Q000627:therapeutic use*; D005260:Female; D019337:Hematologic Neoplasms / Q000150:complications*; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects; D006801:Humans; D055666:Lipopeptides; D008875:Middle Aged; D009503:Neutropenia / Q000150:complications; D014184:Transplantation, Homologous / Q000009:adverse effects; D016896:Treatment Outcome
D000935:Antifungal Agents; D054714:Echinocandins; D055666:Lipopeptides; D000077336:Caspofungin